Siemens, HeartFlow create 3D heart models to treat coronary artery disease

Siemens Healthineers and medical technology company HeartFlow have collaborated on a comprehensive, noninvasive heart technology to help diagnose and manage patients who may have coronary artery disease (CAD).

Heartflow, based in Redwood City, California, and specializing in CAD, will work with Siemens to pair CT scanners from Siemens to the Heartflow FFRct Analysis, a software that creates personalized 3D models of coronary arteries and analyzes blood flow, the companies said in a statement to Cardiovascular Business.

The model can help physicians determine the best course of treatment for patients, and clinical data shows it could help prevent unnecessary angiograms.

The technology is only available in the U.S. right now, but the companies plan to offer it in other countries in the future.

“HeartFlow is pleased to collaborate with Siemens Healthineers, with its outstanding technology, tremendous expertise, and global reach,” said John H. Stevens, MD, chairman and CEO of HeartFlow, in a statement. “Like HeartFlow, Siemens Healthineers is deeply committed to helping clinicians improve the patient experience and clinical outcomes while also helping them to reduce the total cost of healthcare. By working together, we can ensure this technology gets to every patient who can benefit from it.”

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.